A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
Year: 2012
Type: article
Study design: Clinical Trial
Source: Journal of Neurology
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: GW Pharmaceuticals
OpenAlex ID: W1980502203
